BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6735959)

  • 1. Empirical antifungal therapy in neutropenic patients.
    Cohen J
    J Antimicrob Chemother; 1984 May; 13(5):409-11. PubMed ID: 6735959
    [No Abstract]   [Full Text] [Related]  

  • 2. Amphotericin and abolition of fever in neutropenic sepsis.
    Davies SV; Murray JA
    BMJ; 1989 Nov; 299(6711):1339-40. PubMed ID: 2513950
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of persistent fever in the neutropenic patient.
    Bodey GP
    Am J Med; 2000 Mar; 108(4):343-5. PubMed ID: 11014730
    [No Abstract]   [Full Text] [Related]  

  • 4. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Ullmann AJ; Heussel CP; Cornely OA
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
    [No Abstract]   [Full Text] [Related]  

  • 5. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Apisarnthanarak A; Little JR; Tebas P
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041527
    [No Abstract]   [Full Text] [Related]  

  • 6. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ; Pappas P; Winston DJ; Lazarus HM; Petersen F; Raffalli J; Yanovich S; Stiff P; Greenberg R; Donowitz G; Schuster M; Reboli A; Wingard J; Arndt C; Reinhardt J; Hadley S; Finberg R; Laverdière M; Perfect J; Garber G; Fioritoni G; Anaissie E; Lee J;
    N Engl J Med; 2002 Jan; 346(4):225-34. PubMed ID: 11807146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
    Frothingham R
    Clin Infect Dis; 2002 Oct; 35(7):896-7; author reply 897-8. PubMed ID: 12228830
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever.
    Spitzer TR; Creger RJ; Fox RM; Lazarus HM
    Pharmatherapeutica; 1989; 5(5):305-11. PubMed ID: 2748690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical antifungal therapy--new options, new tradeoffs.
    Marr KA
    N Engl J Med; 2002 Jan; 346(4):278-80. PubMed ID: 11807153
    [No Abstract]   [Full Text] [Related]  

  • 10. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Johnson JR
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12037157
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 12. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH; Dixon CA; Goldberger MJ
    N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
    [No Abstract]   [Full Text] [Related]  

  • 13. Empirical antifungal therapy for persistent fever in patients with neutropenia.
    Chandrasekar PH
    Clin Infect Dis; 2001 Jan; 32(2):320-1. PubMed ID: 11170928
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
    Marty M; Gisselbrecht C; Samson-Lepors MJ
    Nouv Presse Med; 1979 Oct; 8(42):3465-8. PubMed ID: 537897
    [No Abstract]   [Full Text] [Related]  

  • 15. Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.
    Stam WB; Aversa F; Kumar RN; Jansen JP
    Value Health; 2008; 11(5):830-41. PubMed ID: 18494752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current antimicrobial usage for the management of neutropenic fever in Korea: a nationwide survey.
    Choi SM; Park SH; Lee DG; Choi JH; Yoo JH; Shin WS
    J Korean Med Sci; 2008 Dec; 23(6):941-7. PubMed ID: 19119433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 18. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Jones BL; McLintock LA
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia].
    Grau S; Marín M; Mateu-de Antonio J
    Med Clin (Barc); 2005 Jan; 124(1):38-9; author reply 39. PubMed ID: 15683629
    [No Abstract]   [Full Text] [Related]  

  • 20. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.